Latest News about VKTX
Recent news which mentions VKTX
From Motley Fool
The Bull Case for Viking Therapeutics Just Got Even Stronger. Here's Why You Should Buy It.
July 29, 2024
Tickers
VKTX
From Motley Fool
From Motley Fool
From Benzinga
From Motley Fool
Novo Nordisk Shares Decline Amid Competitive Pressure
July 25, 2024
From Benzinga
Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
July 25, 2024
From Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 25, 2024
From Benzinga
Viking Therapeutics Stock Surges As Company Advances Weight Loss Drug To Late-Stage Trial: What Investors Need To Know
July 25, 2024
From Benzinga
From Benzinga
IBM Posts Upbeat Earnings, Joins ServiceNow, Helmerich & Payne, RTX, Nasdaq And Other Big Stocks Moving Higher On Thursday
July 25, 2024
From Benzinga
From Benzinga
From InvestorPlace
From InvestorPlace
Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials
July 25, 2024
From InvestorPlace
From InvestorPlace
From Benzinga
From InvestorPlace
Nvidia, Ford, Chipotle, Viking Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today
July 24, 2024
From Benzinga
Tickers
VKTX
From InvestorPlace
Viking Therapeutics Stock Climbs On Q2 EPS Beat
July 24, 2024
From Benzinga
From Benzinga
From Motley Fool
3 Monster Stocks in the Making to Buy Right Now
July 20, 2024
From Motley Fool
3 Undervalued Biotech Stocks With Breakout Potential
July 19, 2024
From InvestorPlace
Is Viking Therapeutics a Millionaire-Maker?
July 19, 2024
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.